Laura Gover, Andrew Anguko, Jane Bruce, Godfrey Magumba, et al.
1
Lee, V.
1
Lenzen, M.
1
Leon-Velarde, F.
1
Lesotho National AIDS Commission, Government of Lesotho
1
Llyod, A.
1
London School of Hygiene and Tropical Medicine
1
López, L.
1
Lucinda Ramos
1
Lukito, A.A., A.U. Rahajoe, L.I. Rilantono, et al.,
1
M. A. Babu
1
M. B. Mello
1
M. Bertram et al.
1
M. Doara, D. Choroliani, P. de Colombani
1
M. Doherty
1
M. F. Silveira
1
M. Gallardo, et al.
1
M. Holtmann
1
M. Joffres
1
M. Kan
1
M. M. Ahmmed
1
M. Odhiambo Sewe, A.M Tompkins et al.
1
M. Penazzato
1
M. Semrau
1
M. Smelyanskaya, J. Duncan
1
M. Sundararaj
1
M. Vitoria
1
M.C. Mollo, et al.
1
M.Johnson
1
M.N. Ngongondo
1
Machalaba
1
MacQuarrie, Kerry L.D., Rebecca Winter, and Sunita Kishor
1
MacQuarrie, Kerry L.D., Sarah E.K. Bradley, Alison Gemmill, and Sarah Staveteig
1
Magitta, N.F.
1
Mailloux, N.A. et al.
1
Mairie de Paris
1
Makatjane, T. J., T. Hlabana, and E. M. Letete
1
Malaria Consortium
1
Malik, A. A.
1
Mangwiro, TNC.
1
March of Dimes
1
Mark W. Rosegrant | Jawoo Koo | Nicola Cenacchi
1
Marselle M., Stadler J., Korn H., et al.
1
Martinez, L.
1
Martínez-Austria Polioptro,F and Bandala E. R
1
Mary De Silva, Lucy Lee& Grace Ryan
1
Mary-Anne Hartley, Alyssa Young, Anh-Minh Tran et al.
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Massoda Tonye, S.G.
1
Matsushita, K.
1
Maurice Bucagu, Jean M. Kagubare, Paulin Basinga, Fidèle Ngabo, Barbara K Timmons & Angela C Lee
1
McCullagh S, Hunter B, Houle K et al.
1
McGahey, Christopher
1
McGloin, J.
1
MCNV, Global Initiative on Psychiatry, and World Granny
1
Mediscript Ltd
1
Melanie Duncan, et al.
1
Mensah, G.A.
1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
1
Meyfroidt, P.
1
Médecins Sans Frontières (MSF)
1
Médecins sans Frontières MSF
1
mhGAP
1
Michael T. Osterholma, Kristine A. Moorea, Nicholas S. Kelley et al.
1
Miller, C.
1
Ministerio de sanidad - España
1
Ministry of Health & Child Welfare
1
Ministry of Health & Family Welfare, India, et al.
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Directorate-General of Health Services, Mycobacterial Disease Control, National Tuberculosis Control Programme
1
Ministry of Health and Social Services (MOHSS)
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health Ethiopia
1
Ministry of Health, Gabarone, Botswana
1
Ministry of Health, Ghana
1
Ministry of Health, Pakistan
1
Ministry of Health, Republic of South Africa
1
Ministry of Health, Republic of Uganda
1
Ministry of Health, South Africa
1
Ministry of Health, Uganda
1
Ministry of Health, Zambia
1
Ministry of Public Health, Quatar
1
Minja, N.W.
1
Mock C. N., Nugent R. et. al.
1
Mock, Charles N.
1
Mohammed A. , Putnis N. et al.
1
Monnier, N.
1
Mont, D.
1
Montelongo, A.
1
Moo-llanes, D.
1
Mortimer, K.
1
Moses, M.W.
1
MSF Access Campaign
1
MSMGF
1
Mukaratirwa, S. et al.
1
Murray, C.J.L.
1
Mutale W.
1
Myanmar Climate Change Alliance (MCCA)
1
Myanmar, Ministry of Health and Sports
1
N. Abera, T. Saballa, et al.
1
N. B. Ahmed
1
N. K. Arora
1
N.I. Agudelo Higuita, S.A. Hamer, et al.
1
NACO, Department of AIDS Control
1
Nakagaayi, D.
1
NASCOP
1
Nat Commun 13, 2788 (2022)
1
National Academy of Sciences of the USA
1
National Agency for Control of AIDS (NACA)
1
National AIDS
1
National AIDS Control Program
1
National AIDS Secretariat
1
National Department of Health South Africa
1
National HIVAIDS Council Zambia
1
National Institute of Disaster Management (NIDM), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
1
National Institute of Environmental Health Sciences
1
National Malaria Elimination Centre, Ministry of Health, Zambia
1
National TB Control Programme, Bangladesh
1
Nature Communications
1
nature medicine
1
Nature Scientific Reports
1
Ncube, M.
1
ndia State-Level Disease Burden Initiative Cancer Collaborators
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Net Hope
1
Niederberger, E.
1
Norwegian Red Cross
1
Norwegian Refugee Council, Internal Displacement Monitoring Centre
1
Nouvellet, P.
1
Nove A., Friberg I., de Bernis L., et al.
1
NSW Health and University of Western Sydney
1
Nugent, Rachel
1
Nunn, Marc
1
Nunziata, K. R.
1
O. Hanssen
1
O. Samoylova
1
O. T. Ranzani
1
OECD
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Oliveira, R.G. de.
1
Olney, Jack J.
1
OMS (WHO)
1
ONUSIDA
1
Organización Mundial de Saude and OPAS
1
Organização Mundial da Saúde (OMS)
1
Ouédraogo M., Samadoulougou S., Rouamba T. et. al.
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...heir HIV status than women. Globally, 78% of men ages 15 years and older who are living with HIV are aware of their HIV status, compared with 86% of women with HIV of these ages.
Offering HIV testing services, including HIV self-testing, at formal and informal workplaces has emerged as an effective, acceptable and feasible approach for reaching men. A 2018 World Health Organization (WHO) and International Labour Organization (ILO) policy brief provides key guiding principles for HIVST implementation at workplaces. Building on the 2018 policy brief, this brief captures early experience with HIVST implementation at workplaces and discusses emerging approaches of sustainable financing that can be adapted for HIV self-testing at workplaces.
The primary audiences for this policy brief are ministries of health and labour, national HIV programmes, employers’ organizations, workers’ organizations (labour unions), enterprises, implementing partners, including civil society organizations, and health insurance agencies.more
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe...w countriesmore
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...erly endemic EU. Using A, F and E, health ministries and their partners have made considerable progress towards achieving this criterion in formerly endemic EUs worldwide. In 2002, an estimated 1517 million people lived in EUs in which EU-wide implementation of the A, F and E components of SAFE were thought to be needed for the purposes of global elimination of trachoma as a public health problem; by June 2021, that number had fallen to 136.2 million, a 91% reduction. Approximately 85% of the 136.2 million people living in EUs needing A, F and E in June 2021 were in WHO’s African Region.more
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the... patient, health-care provider, and health system level prevent the implementation of optimal primary and secondary prevention. Identification of the particular barriers that exist in resource-constrained settings is necessary to inform effective strategies to reduce the identified evidence-practice gaps. Furthermore, targeting modifiable factors that contribute most significantly to the global burden of CVD, including tobacco use, hypertension, and secondary prevention for CVD will lead to the biggest gains in mortality reduction. We review a select number of novel, resource-efficient strategies to reduce premature mortality from CVD, including: (1) effective measures for tobacco control; (2) implementation of simplified screening and management algorithms for those with or at risk of CVD, (3) increasing the availability and affordability of simplified and cost-effective treatment regimens including combination CVD preventive drug therapy, and (4) simplified delivery of health care through task-sharing (non-physician health workers) and optimizing self-management (treatment supporters). Developing and deploying systems of care that address barriers related to the above, will lead to substantial reductions in CVD and related mortality.more
2nd Generation HIV Surveillance in Pakistan, Round 5
The Overall objective of this mapping study was to update population size estimates of selected key populations (PWID, FSWs, MSM & TGs) to create evidence for developing action plans for HIV prevention interventions in Pakistan. A total numbe...r of 23 cities/towns were selected for Mapping. This included 13 cities in Punjab province, 6 in Sindh Province and 2 cities each in KPK and Baluchistan provinces. large file: 70,5 MB The preview/download includes only the pages 1 to 23.more
This report provides an overview of air pollution levels and associated health impacts in cities around the world. Since urban areas are often hotspots for poor air quality, city-level data can help to inform targeted efforts to curb urban air pollution and improve public health. This report draws o...n data from the Global Burden of Disease project and from peer-reviewed analyses led by Susan Anenberg of the George Washington University.more
Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research and updates. In this sense, the objective of the present article was to review studies on the role of wild animals as reservoirs and/or dispersers of etiological age...nts of human infectious diseases in order to compile data on the main wild animals and etiological agents involved in zoonotic outbreaks.more
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...disease-specific programmes and
financing, thus achieving significant progress.more
Antimicrobial resistance (AMR) is a global public health crisis that resulted in 1.14 million deaths in 2021. According to the Institute for Health Metrics and Evaluation estimates, 96 416 of these deaths occurred in the World Health Organization (WHO) Eastern Mediterranean Region. All 22 countr...ies/territories in the Eastern Mediterranean Region are enrolled in the global AMR
surveillance system, and 17 countries/territories reported data in 2024 (for the year 2023). The total number of isolates reported to the system increased sixfold between 2017 and 2022, but the proportion of blood isolates is relatively very low. Most of the data come from public sector laboratories or hospitals, although the private sector has increased its participation in some countries/territories recently. Three pathogens account for three quarters of all the reported pathogens – Escherichia coli
(26%), Klebsiella pneumoniae (23%), and Staphylococcus aureus (22%).more
The African Regional Convening of the Global Initiative to Support Parents (GISP) stimulated the interest or engagement of almost 1500 individuals from 742 unique organizations in the fields of health, education, social welfare, women’s affairs, early childhood, water and sanitation, mental health..., violence prevention, innovative finance, climate, and many others. The convening united representatives across governments, civil society organizations, programme implementers, philanthropies, multilateral organizations, bilateral funders, private companies, universities, schools and day care centres, and hospitals around the common cause of supporting parents and caregivers.more
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...sting programs of the Federal Ministry of Health (FMOH), Federal Ministry of Agriculture and Rural Development (FMARD) and their agencies or institutes. Certain programs and initiatives already have an AMR element incorporated or could,with little effort,include some additional AMR actions, however much is already being planned and has started with existing federal funding and existing staffing and other resources including development partner support and is being driven by significant political will from the ministries as well as implementation support from the Nigerian Centers for Disease Control as the focal point.more
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...that community and hospital pharmacists are involved
into prevent AMR and to reverse AMR rates.more
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...y and the UN SDGs in 2014 and 2015, respectivel
Almost half of the deaths worldwide caused by TB in 2019 occurred in the WHO South-East Asia Region, home to around a quarter of the global population. Maintaining robust progress in this Region is therefore essential if the global goal of ending the TB epidemic is to be realized. Despite substantial gains made in the Region, the threat to
health worldwide posed by the COVID-19 pandemic has the potential to reverse these gains and eclipse the focus on the global TB emergency.
While continuing to tackle COVID-19-related challenges, countries will need to rapidly and urgently deploy supplementary measures to address the large numbers of missed cases, poor treatment outcomes and, potentially, a higher TB burden.
The Regional Strategic Plan towards Ending TB in the Region 2021–2025 clearly articulates priority interventions, analyses the challenges, bottlenecks and opportunities, and focuses on implementation considerations in the Region.more
Summary of the main report: Direct and indirect effects of COVID-19 pandemic and response in South Asia .
It uses a series of exercises based on actual observed changes in services and intervention coverage to model impacts on mortality, hospitalizations, and ICU admissions due to COVID-19. It a...lso models the impact of nationwide stay-at-home orders to curb the spread of COVID-19 on maternal and child mortality, educational attainment of children, and the region’s economy. The study focuses on South Asia’s six most populous countries: Afghanistan, Bangladesh, Nepal, India, Pakistan and Sri Lanka and makes the case for interventions and strategies to minimise these indirect consequences.more
At a time when the world is reeling from the deepest global disruption and health crisis of a lifetime, this year’s Living Planet
report provides unequivocal and alarming evidence that nature is unraveling and that our planet is flashing red warning signs of
vital natural systems failure. The ...Living Planet Report 2020 clearly outlines how humanity’s increasing destruction of nature is having
catastrophic impacts not only on wildlife populations but also on human health and all aspects of our lives.more
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...hat their antibiotics are made responsibly, helping to minimize the risk of AMR in the environment.more